Healthcare - Sector
PASG is currently covered by 3 analysts with an average price target of $14. This is a potential upside of $10.08 (257.14%) from yesterday's end of day stock price of $3.92.
Passage Bio's activity chart (see below) currently has 33 price targets and 51 ratings on display. The stock rating distribution of PASG is 100% BUY.
Analysts' price targets on this stock were met 29.69% of the time, taking 169.75 days on average.
Highest price target for PASG is $23, Lowest price target is $7, average price target is $14.
Most recent stock forecast was given by from CHARDAN CAPITAL on 21-Apr-2026. First documented stock forecast 24-Mar-2020.
Currently out of the existing stock ratings of PASG, 4 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 11-Mar-2022
$7
$2.3 (48.94%)
$21
7 months ago
(21-Apr-2026)
1/4 (25%)
$0.82 (13.27%)
61
Buy Since 27-Feb-2023
$8
$3.3 (70.21%)
$40
7 months ago
(21-Apr-2026)
1/5 (20%)
$1.82 (29.45%)
1152
Buy Since 31-Mar-2026
$15
$11.08 (282.65%)
$30
7 months ago
(21-Apr-2026)
0/2 (0%)
$8.82 (142.72%)
Buy Since 07-Nov-2022
$23
$18.3 (389.36%)
8 months 17 days ago
(04-Mar-2026)
4/5 (80%)
$14.56 (172.51%)
309
Buy Since 03-Feb-2021
$10
1 years 3 months 7 days ago
(14-Aug-2025)
1/2 (50%)
$2.41 (31.75%)
117
What is PASG (Passage Bio) average time for price targets to be met?
Which analyst most recently updated their price target on PASG (Passage Bio)?
Which analyst has the most public recommendations on PASG (Passage Bio)?
Which analyst is the currently most bullish on PASG (Passage Bio)?
Which analyst is the currently most reserved on PASG (Passage Bio)?